Neoadjuvant chemotherapy for breast cancer: Correlation between the baseline MR imaging findings and responses to therapy

European Radiology

Volumn 20, Issue 10, 2010, Pages 2315-2322

  Uematsu, Takayoshi ^a   Kasami, Masako ^a   Yuen, Sachiko ^a  

^a SHIZUOKA CANCER CENTER   (Japan)

Author keywords

Breast cancer; Chemotherapy; Magnetic resonance imaging; Neoadjuvant therapy; Response

Indexed keywords

CYCLOPHOSPHAMIDE; DOCETAXEL; EPIRUBICIN; FLUOROURACIL; HORMONE RECEPTOR; PACLITAXEL; TRASTUZUMAB;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; BREAST CANCER; BREAST NECROSIS; CANCER RESISTANCE; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TREATMENT RESPONSE; TUMOR VOLUME;

ADULT; AGED; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MEDICAL ONCOLOGY; MIDDLE AGED; NECROSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 77957885480     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-010-1813-8     Document Type: Article

References (26)

1. EL Rosen KL Blackwell JA Baker, et al. 2003 Accuracy of MRI in the detection of residual breast cancer after neoadjuvant chemotherapy AJR Am J Roentgenol 181 1275 1282 14573420
2. SC Partridge JE Gibbs Y Lu LJ Esserman D Sudilovsky NM Hylton 2002 Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy AJR Am J Roentgenol 179 1193 1199 12388497
3. V Londero M Bazzocchi CD Frate, et al. 2004 Locally advanced breast cancer: comparison of mammography, sonography and MR imaging in evaluation of residual disease in women receiving neoadjuvant chemotherapy Eur Radiol 14 1371 1379 10.1007/s00330-004-2246-z 14986052
4. C Balu-Maestro C Chapellier A Bleuse I Chanalet C Chauvel R Largillier 2002 Imaging in evaluation of response to neoadjuvant breast cancer treatment benefits of MRI Breast Cancer Res Treat 72 145 152 1:STN:280: DC%2BD383pvVSgsA%3D%3D 10.1023/A:1014856713942 12038705 (Pubitemid 34407209)
5. K Akazawa Y Tamaki T Taguchi, et al. 2006 Preoperative evaluation of residual tumor extent by three-dimensional magnetic resonance imaging in breast cancer patients treated with neoadjuvant chemotherapy Breast J 12 130 137 10.1111/j.1075-122X.2006.00220.x 16509837
6. DC Abraham RC Jones SE Jones, et al. 1996 Evaluation of neoadjuvant chemotherapeutic response of locally advanced breast cancer by magnetic resonance imaging Cancer 78 91 100 1:STN:280:DyaK283ms12huw%3D%3D 10.1002/(SICI)1097-0142(19960701)78:1<91::AID-CNCR14>3.0.CO;2-2 8646731 (Pubitemid 26189909)
7. E Yeh P Slanetz DB Kopans, et al. 2005 Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer AJR Am J Roentgenol 184 868 877 15728611
8. L Esserman E Kaplan S Partridge, et al. 2001 MRI phenotype is associated with response to doxorubicin and cyclophosphamide neoadjuvant chemotherapy in stage 3 breast cancer Ann Surg Oncol 8 549 559 1:STN:280: DC%2BD38%2Fit1eruw%3D%3D 10.1007/s10434-001-0549-8 11456056
9. L Martincich F Montemurro S Cirillo, et al. 2003 Role of magnetic resonance imaging in the prediction of tumor response in patients with locally advanced breast cancer receiving neoadjuvant chemo-therapy Radiol Med 106 51 56 12951551
10. Y Murata Y Ogawa S Yoshida, et al. 2004 Utility of initial MRI for predicting extent of residual disease after neoadjuvant chemotherapy: analysis of 70 breast cancer patients Oncol Rep 12 1257 1262 15547747
11. Ikeda DM, Hylton NM, Kuhl CK et al (2003) Breast imaging reporting and data system, BI-RADS: MRI, 4th edn. American College of Radiology, Reston, VA
12. RL Egan 1982 Multicentric breast carcinomas: clinical-radiographic- pathologic whole organ studies and 10-year survival Cancer 49 1123 1130 1:STN:280:DyaL387js1Khsw%3D%3D 10.1002/1097-0142(19820315)49:6<1123::AID- CNCR2820490610>3.0.CO;2-R 6277457
13. M Kurosumi S Akashi-Tanaka F Akiyama, et al. 2008 Histopathological criteria for assessment of therapeutic response in breast cancer (2007 version) Breast Cancer 15 5 7 10.1007/s12282-007-0016-x 18224386
14. L Esserman N Hylton T George N Weidner 1999 Contrast-enhanced magnetic resonance imaging to assess tumor histopathology and angiogenesis in breast carcinoma Breast J 5 13 21 10.1046/j.1524-4741.1999.005001013.x 11348250 (Pubitemid 29108803)
15. A Rieber H Zeitler H Rosenthal, et al. 1997 MRI of breast cancer: influence of chemotherapy on sensitivity Br J Radiol 70 452 458 1:STN:280:DyaK2szntFSjsg%3D%3D 9227225
16. OI Craciunescu KL Blackwell EL Jones, et al. 2009 DCE-MRI parameters have potential to predict response of locally advanced breast cancer patients to neoadjuvant chemotherapy and hyperthermia: a pilot study Int J Hyperthermia 25 405 415 1:CAS:528:DC%2BD1MXhtlKqt77E 10.1080/02656730903022700 19657852
17. SI Semple RT Staff SD Heys, et al. 2006 Baseline MRI delivery characteristics predict change in invasive ductal breast carcinoma PET metabolism as a result of primary chemotherapy administration Ann Oncol 17 1393 1398 1:STN:280:DC%2BD28rktVensQ%3D%3D 10.1093/annonc/mdl136 16788001 (Pubitemid 44400377)
18. ER Fisher S Anderson C Redmond B Fisher 1993 Pathologic findings from the National Surgical Adjuvant Breast Project B-06. 10-year pathologic and clinical prognostic discriminants Cancer 71 2507 2514 1:STN:280:DyaK3s3gtFCktw%3D%3D 10.1002/1097-0142(19930415)71:8<2507::AID-CNCR2820710813>3.0.CO;2-0 8453574 (Pubitemid 23100484)
19. RE Jimenez T Wallis DW Visscher 2001 Centrally necrotizing carcinoma of the breast: a distinct histologic subtype with aggressive clinical behavior Am J Surg Pathol 25 331 337 1:STN:280:DC%2BD3M7lvFeqsw%3D%3D 10.1097/00000478- 200103000-00007 11224603 (Pubitemid 32174202)
20. RD Leek RJ Landers AL Harris CE Lewis 1999 Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast Br J Cancer 79 991 995 1:STN:280:DyaK1M7mvVCmsg%3D%3D 10.1038/sj.bjc.6690158 10070902 (Pubitemid 29082138)
21. S Metz HE Daldrup-Link T Richter, et al. 2003 Detection and quantification of breast tumor necrosis with MR imaging: value of the necrosis-avid contrast agent gadophrin-3 Acad Radiol 10 484 490 10.1016/S1076-6332(03)80056-9 12755535 (Pubitemid 36534889)
22. T Uematsu M Kasami S Yuen 2009 Triple-negative breast cancer: correlation between MR imaging and pathologic findings Radiology 250 638 647 10.1148/radiol.2503081054 19244039
23. N Tamura T Hasebe N Okada, et al. 2009 Tumor histology in lymph vessels and lymph nodes for the accurate prediction of outcome among breast cancer patients treated with neoadjuvant chemotherapy Cancer Sci 100 1823 1833 1:CAS:528:DC%2BD1MXht12qs7vF 10.1111/j.1349-7006.2009.01264.x 19604245
24. M Tubiana-Hulin D Stevens S Lasry, et al. 2006 Response to neoadjuvant chemotherapy in lobular and ductal breast carcinomas: a retrospective study on 860 patients from one institution Ann Oncol 17 1228 1233 1:STN:280: DC%2BD28vkvVOrsA%3D%3D 10.1093/annonc/mdl114 16740599 (Pubitemid 44288213)
25. M Cristofanilli A Gonzalez-Angulo N Sneige, et al. 2005 Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes J Clin Oncol 23 41 48 10.1200/JCO.2005.03.111 15625359 (Pubitemid 41702621)
26. JH Chen B Feig G Agrawal, et al. 2008 MRI evaluation of pathologically complete response and residual tumors in breast cancer after neoadjuvant chemotherapy Cancer 112 17 26 10.1002/cncr.23130 18000804